Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease

Summary We describe the findings from a national study of maternal and fetal outcomes of pregnancy in women with sickle cell disease (SCD). Data were collected via the United Kingdom Obstetric Surveillance System between 1 February 2010 and 31 January 2011 from 109 women, of whom 51 (46·8%) had HbSS...

Full description

Saved in:
Bibliographic Details
Published in:British journal of haematology 2015-04, Vol.169 (1), p.129-137
Main Authors: Oteng‐Ntim, Eugene, Ayensah, Benjamin, Knight, Marian, Howard, Jo
Format: Article
Language:English
Subjects:
Acute Pain - epidemiology
Adult
Birth Weight
Epidemiological Monitoring
Female
Fetal Diseases
haemoglobinopathy
Hemoglobin SC Disease
Humans
Incidence
Live Birth
Pregnancy
Pregnancy Complications, Infectious - epidemiology
sickle
United Kingdom
Urinary Tract Infections - epidemiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 137
container_issue 1
container_start_page 129
container_title British journal of haematology
container_volume 169
creator Oteng‐Ntim, Eugene
Ayensah, Benjamin
Knight, Marian
Howard, Jo
description Summary We describe the findings from a national study of maternal and fetal outcomes of pregnancy in women with sickle cell disease (SCD). Data were collected via the United Kingdom Obstetric Surveillance System between 1 February 2010 and 31 January 2011 from 109 women, of whom 51 (46·8%) had HbSS and 44 (40·4%) had HbSC. Data included antenatal, maternal and fetal outcomes. Comparisons were made between women with HbSS and HbSC. Incidence of complications were acute pain (57%), blood transfusion (26%), urinary tract infection (UTI; 12%) and critical care unit admission (23%) and these were all more common in women with HbSS than HbSC. There was no difference in the incidence of acute chest syndrome, hypertension and venous thromboembolism between HbSS and HbSC. Women with HbSS were more likely to deliver at
doi_str_mv 10.1111/bjh.13270
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753470851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1664445666</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3540-564300e953cb8ba77b8ab671c274c41cace0a93a9f1ad2956a85d9634dbbb1253</originalsourceid><addsrcrecordid>eNqFkUtOwzAQhi0EoqWw4ALIS1iE2vEjyRIqoDwkkErX0dgx1CVxQpyoyo47cENOQmgBiRWzmbHmm9-j-RE6pOSU9jFWy8UpZWFEttCQMimCkHK6jYaEkCighMcDtOf9khDKiKC7aBAKEfZMOETvD7V5duB0h8u20WVhsHW4gsYa13i8ss0Ce6tfcoO1yXOcWW_Ar6FmYfD8Fn-8vWPArp8oHeRYl4uybrBv2qzrH0UFtXXPfzTAgSks4OOpms1ONn_05eRHfB_tPEHuzcF3HqH55cXjZBrc3V9dT87ugooJTgIhOSPEJIJpFSuIIhWDkhHVYcQ1pxq0IZAwSJ4oZGEiJMQiSyTjmVKKhoKN0PFGt6rL19b4Ji2s_9oQnClbn9JIMB6RWND_USk550JK2aNH32irCpOlVW0LqLv05-Y9MN4AK5ub7rdPSfplZtqbma7NTM9vpuuCfQL1HZHI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664445666</pqid></control><display><type>article</type><title>Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Oteng‐Ntim, Eugene ; Ayensah, Benjamin ; Knight, Marian ; Howard, Jo</creator><creatorcontrib>Oteng‐Ntim, Eugene ; Ayensah, Benjamin ; Knight, Marian ; Howard, Jo</creatorcontrib><description>Summary We describe the findings from a national study of maternal and fetal outcomes of pregnancy in women with sickle cell disease (SCD). Data were collected via the United Kingdom Obstetric Surveillance System between 1 February 2010 and 31 January 2011 from 109 women, of whom 51 (46·8%) had HbSS and 44 (40·4%) had HbSC. Data included antenatal, maternal and fetal outcomes. Comparisons were made between women with HbSS and HbSC. Incidence of complications were acute pain (57%), blood transfusion (26%), urinary tract infection (UTI; 12%) and critical care unit admission (23%) and these were all more common in women with HbSS than HbSC. There was no difference in the incidence of acute chest syndrome, hypertension and venous thromboembolism between HbSS and HbSC. Women with HbSS were more likely to deliver at &lt;37 weeks gestation (P = 0·01) and their babies were more likely to have reduced birth weight. Delivery at &lt;34 weeks was increased in both HbSS and HbSC women (5·9% vs. 4·6%) compared to national data. This study confirms a high rate of maternal and fetal complications in mothers with SCD, even in women with HbSC, which has previously been considered to have a more benign phenotype in pregnancy.</description><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/bjh.13270</identifier><identifier>PMID: 25522142</identifier><language>eng</language><publisher>England</publisher><subject>Acute Pain - epidemiology ; Adult ; Birth Weight ; Epidemiological Monitoring ; Female ; Fetal Diseases ; haemoglobinopathy ; Hemoglobin SC Disease ; Humans ; Incidence ; Live Birth ; Pregnancy ; Pregnancy Complications, Infectious - epidemiology ; sickle ; United Kingdom ; Urinary Tract Infections - epidemiology</subject><ispartof>British journal of haematology, 2015-04, Vol.169 (1), p.129-137</ispartof><rights>2014 John Wiley &amp; Sons Ltd</rights><rights>2014 John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25522142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Oteng‐Ntim, Eugene</creatorcontrib><creatorcontrib>Ayensah, Benjamin</creatorcontrib><creatorcontrib>Knight, Marian</creatorcontrib><creatorcontrib>Howard, Jo</creatorcontrib><title>Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><description>Summary We describe the findings from a national study of maternal and fetal outcomes of pregnancy in women with sickle cell disease (SCD). Data were collected via the United Kingdom Obstetric Surveillance System between 1 February 2010 and 31 January 2011 from 109 women, of whom 51 (46·8%) had HbSS and 44 (40·4%) had HbSC. Data included antenatal, maternal and fetal outcomes. Comparisons were made between women with HbSS and HbSC. Incidence of complications were acute pain (57%), blood transfusion (26%), urinary tract infection (UTI; 12%) and critical care unit admission (23%) and these were all more common in women with HbSS than HbSC. There was no difference in the incidence of acute chest syndrome, hypertension and venous thromboembolism between HbSS and HbSC. Women with HbSS were more likely to deliver at &lt;37 weeks gestation (P = 0·01) and their babies were more likely to have reduced birth weight. Delivery at &lt;34 weeks was increased in both HbSS and HbSC women (5·9% vs. 4·6%) compared to national data. This study confirms a high rate of maternal and fetal complications in mothers with SCD, even in women with HbSC, which has previously been considered to have a more benign phenotype in pregnancy.</description><subject>Acute Pain - epidemiology</subject><subject>Adult</subject><subject>Birth Weight</subject><subject>Epidemiological Monitoring</subject><subject>Female</subject><subject>Fetal Diseases</subject><subject>haemoglobinopathy</subject><subject>Hemoglobin SC Disease</subject><subject>Humans</subject><subject>Incidence</subject><subject>Live Birth</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Infectious - epidemiology</subject><subject>sickle</subject><subject>United Kingdom</subject><subject>Urinary Tract Infections - epidemiology</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkUtOwzAQhi0EoqWw4ALIS1iE2vEjyRIqoDwkkErX0dgx1CVxQpyoyo47cENOQmgBiRWzmbHmm9-j-RE6pOSU9jFWy8UpZWFEttCQMimCkHK6jYaEkCighMcDtOf9khDKiKC7aBAKEfZMOETvD7V5duB0h8u20WVhsHW4gsYa13i8ss0Ce6tfcoO1yXOcWW_Ar6FmYfD8Fn-8vWPArp8oHeRYl4uybrBv2qzrH0UFtXXPfzTAgSks4OOpms1ONn_05eRHfB_tPEHuzcF3HqH55cXjZBrc3V9dT87ugooJTgIhOSPEJIJpFSuIIhWDkhHVYcQ1pxq0IZAwSJ4oZGEiJMQiSyTjmVKKhoKN0PFGt6rL19b4Ji2s_9oQnClbn9JIMB6RWND_USk550JK2aNH32irCpOlVW0LqLv05-Y9MN4AK5ub7rdPSfplZtqbma7NTM9vpuuCfQL1HZHI</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Oteng‐Ntim, Eugene</creator><creator>Ayensah, Benjamin</creator><creator>Knight, Marian</creator><creator>Howard, Jo</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>201504</creationdate><title>Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease</title><author>Oteng‐Ntim, Eugene ; Ayensah, Benjamin ; Knight, Marian ; Howard, Jo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3540-564300e953cb8ba77b8ab671c274c41cace0a93a9f1ad2956a85d9634dbbb1253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Acute Pain - epidemiology</topic><topic>Adult</topic><topic>Birth Weight</topic><topic>Epidemiological Monitoring</topic><topic>Female</topic><topic>Fetal Diseases</topic><topic>haemoglobinopathy</topic><topic>Hemoglobin SC Disease</topic><topic>Humans</topic><topic>Incidence</topic><topic>Live Birth</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Infectious - epidemiology</topic><topic>sickle</topic><topic>United Kingdom</topic><topic>Urinary Tract Infections - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oteng‐Ntim, Eugene</creatorcontrib><creatorcontrib>Ayensah, Benjamin</creatorcontrib><creatorcontrib>Knight, Marian</creatorcontrib><creatorcontrib>Howard, Jo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oteng‐Ntim, Eugene</au><au>Ayensah, Benjamin</au><au>Knight, Marian</au><au>Howard, Jo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2015-04</date><risdate>2015</risdate><volume>169</volume><issue>1</issue><spage>129</spage><epage>137</epage><pages>129-137</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><abstract>Summary We describe the findings from a national study of maternal and fetal outcomes of pregnancy in women with sickle cell disease (SCD). Data were collected via the United Kingdom Obstetric Surveillance System between 1 February 2010 and 31 January 2011 from 109 women, of whom 51 (46·8%) had HbSS and 44 (40·4%) had HbSC. Data included antenatal, maternal and fetal outcomes. Comparisons were made between women with HbSS and HbSC. Incidence of complications were acute pain (57%), blood transfusion (26%), urinary tract infection (UTI; 12%) and critical care unit admission (23%) and these were all more common in women with HbSS than HbSC. There was no difference in the incidence of acute chest syndrome, hypertension and venous thromboembolism between HbSS and HbSC. Women with HbSS were more likely to deliver at &lt;37 weeks gestation (P = 0·01) and their babies were more likely to have reduced birth weight. Delivery at &lt;34 weeks was increased in both HbSS and HbSC women (5·9% vs. 4·6%) compared to national data. This study confirms a high rate of maternal and fetal complications in mothers with SCD, even in women with HbSC, which has previously been considered to have a more benign phenotype in pregnancy.</abstract><cop>England</cop><pmid>25522142</pmid><doi>10.1111/bjh.13270</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-1048
ispartof British journal of haematology, 2015-04, Vol.169 (1), p.129-137
issn 0007-1048
1365-2141
language eng
recordid cdi_proquest_miscellaneous_1753470851
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Acute Pain - epidemiology
Adult
Birth Weight
Epidemiological Monitoring
Female
Fetal Diseases
haemoglobinopathy
Hemoglobin SC Disease
Humans
Incidence
Live Birth
Pregnancy
Pregnancy Complications, Infectious - epidemiology
sickle
United Kingdom
Urinary Tract Infections - epidemiology
title Pregnancy outcome in patients with sickle cell disease in the UK – a national cohort study comparing sickle cell anaemia (HbSS) with HbSC disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A02%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pregnancy%20outcome%20in%20patients%20with%20sickle%20cell%20disease%20in%20the%20UK%20%E2%80%93%20a%20national%20cohort%20study%20comparing%20sickle%20cell%20anaemia%20(HbSS)%20with%20HbSC%20disease&rft.jtitle=British%20journal%20of%20haematology&rft.au=Oteng%E2%80%90Ntim,%20Eugene&rft.date=2015-04&rft.volume=169&rft.issue=1&rft.spage=129&rft.epage=137&rft.pages=129-137&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/bjh.13270&rft_dat=%3Cproquest_pubme%3E1664445666%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p3540-564300e953cb8ba77b8ab671c274c41cace0a93a9f1ad2956a85d9634dbbb1253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1664445666&rft_id=info:pmid/25522142&rfr_iscdi=true